Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition.
暂无分享,去创建一个
Sheung Tat Fan | Warren Leonard | W. Leonard | S. Fan | I. Ng | R. Poon | T. Lee | K. Man | C. Lo | A. Yuen | Kwan Man | Chung Mau Lo | Ronnie T P Poon | Terence K Lee | Anthony P Yuen | Irene O Ng | Kevin T Ng | K. Ng
[1] S. Ye,et al. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. , 2001, World journal of gastroenterology.
[2] S. Fan,et al. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. , 2000, Annals of surgery.
[3] S. Hirohashi. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. , 1998, The American journal of pathology.
[4] Alan Cantor,et al. Activation of Stat3 in Primary Tumors from High-Risk Breast Cancer Patients Is Associated with Elevated Levels of Activated Src and Survivin Expression , 2006, Clinical Cancer Research.
[5] K. Sugimachi,et al. Altered Expression of β-Catenin without Genetic Mutation in Intrahepatic Cholangiocarcinoma , 2001, Modern Pathology.
[6] J. Xie,et al. Signal transducer and activator of transcription-5 activation and breast cancer prognosis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] B. Beattie,et al. Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling. , 1999, Blood.
[8] J. Rosen,et al. Signal transducers and activators of transcription 5B potentiates v-Src-mediated transformation of NIH-3T3 cells. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[9] C. Janeway,et al. STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation. , 1999, Science.
[10] Jens Schneider-Mergener,et al. SHP2 and SOCS3 Contribute to Tyr-759-dependent Attenuation of Interleukin-6 Signaling through gp130* , 2003, The Journal of Biological Chemistry.
[11] S. Parsons,et al. STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor* , 2003, The Journal of Biological Chemistry.
[12] H. Adami,et al. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis , 2001, Hepatology.
[13] A. Capovilla,et al. Putative role of hepatitis B virus X protein in hepatocarcinogenesis: Effects on apoptosis, DNA repair, mitogen‐activated protein kinase and JAK/STAT pathways , 2000, Journal of gastroenterology and hepatology.
[14] R. Snell,et al. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[15] W. Leonard,et al. Cloning of Human Stat5B , 1996, The Journal of Biological Chemistry.
[16] E. Gehan,et al. Activation of Signal Transducer and Activator of Transcription-5 in Prostate Cancer Predicts Early Recurrence , 2005, Clinical Cancer Research.
[17] E. Gehan,et al. Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers , 2004, International journal of cancer.
[18] B. Groner,et al. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. , 1995, The EMBO journal.
[19] H. Rui,et al. STAT5a activation mediates the epithelial to mesenchymal transition induced by oncogenic RhoA. , 2003, Molecular biology of the cell.
[20] Matthew B. Wilson,et al. The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells , 2002, The EMBO journal.
[21] J. Xie,et al. Activation of Signal Transducer and Activator of Transcription 5 in Human Prostate Cancer Is Associated with High Histological Grade , 2004, Cancer Research.
[22] M. Mitsunobu,et al. Intrahepatic metastases in hepatocellular carcinoma: evidence for spread via the portal vein as an efferent vessel. , 1996, The American journal of gastroenterology.
[23] Y. Yun,et al. HBx Protein of Hepatitis B Virus Activates Jak1-STAT Signaling* , 1998, The Journal of Biological Chemistry.
[24] P. Coffer,et al. The role of STATs in myeloid differentiation and leukemia , 2000, Oncogene.
[25] J. Grandis,et al. Constitutive activation of Stat5b contributes to carcinogenesis in vivo. , 2003, Cancer research.
[26] N. Nagasue,et al. Proposal of invasiveness score to predict recurrence and survival after curative hepatic resection for hepatocellular carcinoma. , 1997, Surgery.
[27] R. Behringer,et al. Twist function is required for the morphogenesis of the cephalic neural tube and the differentiation of the cranial neural crest cells in the mouse embryo. , 2002, Developmental biology.
[28] F. Portillo,et al. Transcriptional regulation of cadherins during development and carcinogenesis. , 2004, The International journal of developmental biology.
[29] J. Grandis,et al. Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis. , 2007, Journal of the National Cancer Institute.
[30] Heinz Höfler,et al. Mutations of the human E‐cadherin (CDH1) gene , 1998, Human mutation.
[31] A. Sultan,et al. Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells , 2005, Oncogene.
[32] T. Yamane,et al. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. , 1982, Cancer research.
[33] H. Endo,et al. Thrombopoietin Regulates Bcl-xL Gene Expression through Stat5 and Phosphatidylinositol 3-Kinase Activation Pathways* , 2002, The Journal of Biological Chemistry.
[34] S. Ramaswamy,et al. Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.